Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Multiple sclerosis enters a grey area

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature 566, 465-466 (2019)

doi: https://doi.org/10.1038/d41586-019-00563-6

References

  1. 1.

    The International Multiple Sclerosis Genetics Consortium. Nature 476, 214–219 (2011).

    PubMed  Article  Google Scholar 

  2. 2.

    Lodygin, D. et al. Nature 566, 503–508 (2019).

    Article  Google Scholar 

  3. 3.

    Stern, J. N. et al. Sci. Transl. Med. 6, 248ra107248ra107 (2014).

    Article  Google Scholar 

  4. 4.

    Dendrou, C. A., Fugger, L. & Friese, M. A. Nature Rev. Immunol. 15, 545–558 (2015).

    PubMed  Article  Google Scholar 

  5. 5.

    Ota, K. et al. Nature 346, 183–187 (1990).

    PubMed  Article  Google Scholar 

  6. 6.

    Cao, Y. et al. Sci. Transl. Med. 7, 287ra74 (2015).

    PubMed  Article  Google Scholar 

  7. 7.

    Jelcic, I. et al. Cell 175, 85–100 (2018).

    PubMed  Article  Google Scholar 

  8. 8.

    Lucchinetti, C. F. et al. N. Engl. J. Med. 365, 2188–2197 (2011).

    PubMed  Article  Google Scholar 

  9. 9.

    Calabrese, M. et al. Brain 135, 2952–2961 (2012).

    PubMed  Article  Google Scholar 

  10. 10.

    Brown, J. W. L. et al. J. Am. Med. Assoc. 321, 175–187 (2019).

    Article  Google Scholar 

  11. 11.

    Mor, F., Quintana, F., Mimran, A. & Cohen, I. R. J. Immunol. 170, 628–634 (2003).

    PubMed  Article  Google Scholar 

  12. 12.

    Sulzer, D. et al. Nature 546, 656–661 (2017).

    PubMed  Article  Google Scholar 

  13. 13.

    Vargas, K. J. et al. J. Neurosci. 34, 9364–9376 (2014).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

D.A.H. has received funding from Bristol-Myers Squibb, Novartis and Genentech. D.A.H. has been a consultant for Compass Therapeutics, EMD Serono, Novartis Pharmaceuticals, Sanofi Genzyme and Versant Venture, Genentech and Proclara Bioscience.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links